Literature DB >> 26992450

Epidemiological analysis of psoriatic arthritis patients in Japan.

Toshiyuki Yamamoto1, Mamitaro Ohtsuki2, Shigetoshi Sano3, Atsuyuki Igarashi4, Akimichi Morita5, Ryuhei Okuyama6, Akira Kawada7.   

Abstract

To determine the current status of psoriatic arthritis, we conducted a retrospective survey by sending questionnaires. The newly visited psoriatic arthritis patients accounted for 10.5% (95% confidence interval, 7.9-13%) of all newly visited psoriasis patients (n = 2581) between April 2014 and March 2015 in 73 institutes. Additionally, questionnaires on detailed patients' information were returned by 92 institutes (response rate, 70.8%), where 1282 patients with psoriatic arthritis were identified. There was a male predominance. The mean onset age of psoriatic arthritis was 44.9 years, and mean onset age for cutaneous psoriasis (36.4 years) was lower than that for arthritis (45.1 years). The mean duration in patients who developed psoriasis prior to arthritis was 11.2 years, while that in patients preceded by arthritis was 4.4 years. According to the Moll and Wright criteria, polyarthritis type was most common (36%), followed by distal interphalangeal type (26%) and oligoarthritis type (22%). Peripheral joint pain was 61.5%, back pain such as lumbago and neck pain was 34.3%. Enthesitis and dactylitis were observed in 28.3% and 59.2%, respectively. Biologics were used in 55.5% of psoriatic arthritis patients, and 31% used disease-modifying antirheumatic drugs. In conclusion, the ratio of psoriatic arthritis in Japan is increasing, and nearly 10% of new psoriasis patients had psoriatic arthritis. This study shows the current status of psoriatic arthritis in Japan, including several unexpected findings such as male predominance, longer duration between the onset of cutaneous psoriasis and arthritis, and dominance of polyarthritis.
© 2016 Japanese Dermatological Association.

Entities:  

Keywords:  Asia; Japan; dermatology; epidemiology; psoriatic arthritis

Mesh:

Substances:

Year:  2016        PMID: 26992450     DOI: 10.1111/1346-8138.13342

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  9 in total

Review 1.  Autoimmunity and autoimmune co-morbidities in psoriasis.

Authors:  Kazuhisa Furue; Takamichi Ito; Gaku Tsuji; Takafumi Kadono; Takeshi Nakahara; Masutaka Furue
Journal:  Immunology       Date:  2018-02-06       Impact factor: 7.397

Review 2.  "Inflammatory skin march" in atopic dermatitis and psoriasis.

Authors:  Masutaka Furue; Takafumi Kadono
Journal:  Inflamm Res       Date:  2017-06-15       Impact factor: 4.575

Review 3.  Sex- and gender-related differences in psoriatic arthritis.

Authors:  Sanjana Tarannum; Ying-Ying Leung; Sindhu R Johnson; Jessica Widdifield; Vibeke Strand; Paula Rochon; Lihi Eder
Journal:  Nat Rev Rheumatol       Date:  2022-08-04       Impact factor: 32.286

4.  Delayed Diagnosis of Psoriatic Arthritis Mutilans due to Arthritis Prior to Skin Lesion.

Authors:  Takeshi Mochizuki; Katsunori Ikari; Ken Okazaki
Journal:  Case Rep Rheumatol       Date:  2018-11-04

5.  Quantitative analysis of therapeutic response in psoriatic arthritis of digital joints with Dual-energy CT iodine maps.

Authors:  Reina Kayama; Takeshi Fukuda; Sho Ogiwara; Mami Momose; Tadashi Tokashiki; Yoshinori Umezawa; Akihiko Asahina; Kunihiko Fukuda
Journal:  Sci Rep       Date:  2020-01-27       Impact factor: 4.379

Review 6.  Diagnosis and Intervention in Early Psoriatic Arthritis.

Authors:  Tomoyuki Hioki; Mayumi Komine; Mamitaro Ohtsuki
Journal:  J Clin Med       Date:  2022-04-06       Impact factor: 4.241

7.  Clinical Characteristics of Patients With Psoriatic Spondylitis Versus Those With Ankylosing Spondylitis: Features at Baseline Before Biologic Therapy.

Authors:  Hyoun-Ah Kim; Eunyoung Lee; So Young Park; Shin-Seok Lee; Kichul Shin
Journal:  J Korean Med Sci       Date:  2022-08-22       Impact factor: 5.354

Review 8.  Cardiovascular and Metabolic Diseases Comorbid with Psoriasis: Beyond the Skin.

Authors:  Masutaka Furue; Gaku Tsuji; Takahito Chiba; Takafumi Kadono
Journal:  Intern Med       Date:  2017-07-01       Impact factor: 1.271

9.  Real-World Postmarketing Study of the Impact of Adalimumab Treatment on Work Productivity and Activity Impairment in Patients with Psoriatic Arthritis.

Authors:  Hidemi Nakagawa; Yoshiya Tanaka; Shigetoshi Sano; Hideto Kameda; Atsuo Taniguchi; Tomoko Kashiwagi; Takeshi Kawaberi; Junko Kimura; Akimichi Morita
Journal:  Adv Ther       Date:  2019-01-19       Impact factor: 3.845

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.